Jeremy Saklatvala

Imperial College London

Papers

1

Total Citations

162

H-Index

1

About

Jeremy Saklatvala is a leading figure in cartilage biology and osteoarthritis research, whose work has fundamentally advanced our understanding of joint disease at the molecular level. His key contributions lie in proteomic analysis of articular cartilage, where he pioneered techniques to identify and quantify proteins involved in cartilage homeostasis and pathology. His landmark 2004 study, cited over 160 times, demonstrated that proteomic approaches could be applied to cartilage pathophysiology, revealing increased type II collagen synthesis in osteoarthritis and identifying inhibin βA (activin A) as a novel regulatory molecule for chondrocytes. This work provided critical insights into the anabolic and catabolic processes driving osteoarthritis, establishing activin A as a potential therapeutic target. Saklatvala’s research has had lasting impact on the field, bridging basic cartilage biology with clinical disease mechanisms. His methodological innovations in two-dimensional SDS-PAGE and mass spectrometry analysis of cartilage explants have enabled subsequent studies to probe the complex protein networks governing joint health. For students and researchers, his work exemplifies how combining classical biochemistry with emerging proteomic technologies can uncover fundamental disease mechanisms and open new avenues for therapeutic intervention in osteoarthritis.

Research Focus

Key Achievements

1
H-Index
1
Papers
162
Total Citations
162
Avg Citations/Paper
🏆 Most Cited Paper
Proteomic Analysis of Articular Cartilage Shows Increased Type II Collagen Synthesis in Osteoarthritis and Expression of Inhibin βA (Activin A), a Regulatory Molecule for Chondrocytes
162 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Imperial College London

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago